Latest Headlines

  1. GE Healthcare Life Sciences Allies With Pharmadule Morimatsu To Expand KUBio
    12/5/2019

    The KUBio “factory in a box” is expanding to accelerate the accessibility of biotherapeutics on a global scale. Additional modular platforms will be introduced in 2020 allowing biopharma manufacturers to quickly scale up vaccines, viral vector-based therapies, and other novel modalities.

  2. Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Massachusetts
    12/5/2019

    New facility will create 200 new jobs and accelerate commercialization of gene and cell therapies.

  3. VGXI Selects BE&K As Design Firm For New 240,000 Square Foot Manufacturing Facility
    12/3/2019

    VGXI, a highly regarded CDMO supporting the gene therapy and DNA vaccine industries, announces it has chosen the integrated construction services company BE&K Building Group as Design-Build Partner for the initial phase of its new manufacturing site.

  4. Astellas Buys Audentes Therapeutics For $3B For Gene Therapy Drug Manufacturing Expansion
    12/2/2019

    Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Audentes Therapeutics, Inc. (Chairman and CEO: Matthew R. Patterson, “Audentes”), today announced that they have entered into a definitive agreement for Astellas to acquire Audentes at a price of US$60.00 per share in cash, representing a total equity value of approximately US$3B.

  5. Speeding Cell, Gene Therapy Development
    11/25/2019

    An innovative new major private-public partnership led by Harvard and MIT aims to accelerate one of the hottest and most promising areas of medical research: cell and gene therapy

  6. Premier Research Renews Sponsorship For World Orphan Drug Congress Europe
    11/8/2019

    Premier Research is proud to once again be a sponsor of the World Orphan Drug Congress (WODC) Europe taking place November 12-14, 2019, in Barcelona, Spain. As part of our ongoing support for this innovative conference, Jonathan Kornstein, Executive Director, Program Strategy, Rare Disease & Pediatrics, will present a session entitled "A Partnership That Lasts: Key Considerations When Working With CROs on Rare Disease Studies."

  7. IPS Announces New Office In Cherry Hill, NJ For Pharma, Cell / Gene / Bio Clients
    11/7/2019

    IPS-Integrated Project Services, LLC, a leading provider of Engineering, Procurement, Construction Management and Commissioning, Qualification, and Validation (EPCM/CQV) services, announces the continued expansion in the Americas region with the opening of a new office located in Cherry Hill, New Jersey.

  8. AES Announces Sales Manager Opening For Western US Region
    10/31/2019

    The Sales Manager has primary responsibility for AES business development activities within the Western Region.

  9. ISPE Announces CRB As 2019 Company Of The Year At Annual Meeting
    10/30/2019

    CRB was recognized as the 2019Company of the Yearby the International Society for Pharmaceutical Engineering (ISPE) during the organization's annual meeting inLas Vegas, Nevadaon Oct. 27–30, 2019.

  10. Prelude Therapeutics Announces Investment And Expansion Of Labs In Delaware
    10/30/2019

    Prelude Therapeutics, a privately-held, clinical-stage biopharmaceutical company, will invest $5M in expanded lab and office space in metro Wilmington, Delaware.